162 related articles for article (PubMed ID: 9750919)
1. Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.
Cullis PA; O'Brien CF; Truong DD; Koller M; Villegas TP; Wallace JD
Adv Neurol; 1998; 78():227-30. PubMed ID: 9750919
[No Abstract] [Full Text] [Related]
2. Botulinum toxin in cervical dystonia.
Tsui JK; Calne DB
Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
[No Abstract] [Full Text] [Related]
3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
4. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.
Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W;
Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831
[TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin in the treatment of cervical dystonia.
Poewe W; Wissel J
Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
[TBL] [Abstract][Full Text] [Related]
7. Cervical dystonia: a review the role of botulinum toxin.
Edwards LL; Normand MM; Wszolek ZK
Nebr Med J; 1995 May; 80(5):109-15. PubMed ID: 7791942
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin.
Metzer WS; Jenkins T
J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180
[TBL] [Abstract][Full Text] [Related]
9. [Dystonia as the cause of pharyngolaryngeal motility disorders].
Zwirner P; Dressler D
HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
[TBL] [Abstract][Full Text] [Related]
10. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
[No Abstract] [Full Text] [Related]
11. No effects on heart-rate variability and cardiovascular reflex tests after botulinum toxin treatment of cervical dystonia.
Nebe A; Schelosky L; Wissel J; Ebersbach G; Scholz U; Poewe W
Mov Disord; 1996 May; 11(3):337-9. PubMed ID: 8723158
[No Abstract] [Full Text] [Related]
12. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
Kaufman DM
J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement.
Novak I; Campbell L; Boyce M; Fung VS;
Eur J Neurol; 2010 Aug; 17 Suppl 2():94-108. PubMed ID: 20633181
[TBL] [Abstract][Full Text] [Related]
14. Time course of distant effects of local injections of botulinum toxin.
Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.
Lu CS; Chen RS; Tsai CH
J Formos Med Assoc; 1995 Apr; 94(4):189-92. PubMed ID: 7606182
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
Lew MF; Brashear A; Factor S
Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.
Kojovic M; Caronni A; Bologna M; Rothwell JC; Bhatia KP; Edwards MJ
Mov Disord; 2011 Jun; 26(7):1282-9. PubMed ID: 21469207
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
19. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin.
Dykstra D; Ellingham C; Belfie A; Baxter T; Lee M; Voelker A
Mov Disord; 1993; 8(1):38-42. PubMed ID: 8419806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
